The global negative pressure wound therapy market size was valued at USD 2.0 billion in 2021 and is expected to witness a compound annual growth rate (CAGR) of 6.7% from 2022 to 2030. Increasing demand for advanced wound care is expected to drive the market for Negative Pressure Wound Therapy (NPWT). Single-use NPWT devices are gaining traction in the field of wound care management over conventional products. For instance, major players like Smith & Nephew introduced a single-use NPWT, PICO, which has gained huge acceptability worldwide. The increasing prevalence of chronic diseases, such as diabetes, is anticipated to impact the industry demand to a large extent. This is primarily attributable to the fact that diabetes often results in complications such as diabetic foot ulcers.
The rapid spread of the COVID-19 virus has led to a global pandemic, triggering the disruption of healthcare services, including the medical care of patients with wounds. Due to the need, the provision of wound care, which ought to be viewed as a fundamental clinical service, has shifted drastically. During the pandemic, the major objectives of negative pressure wound therapy shifted from complete healing of wounds to avoiding serious complications to minimize surgery and hospitalization. Due to the effect of the pandemic on major manufacturers, production has significantly reduced causing an increase in the costs of wound dressings.
The majority of wounds are caused by transport injuries and road accidents are one of the major drivers of the market. Since the pandemic brought about the complete cancellation of public and private transportation, the number of patients with wounds requiring medical care has significantly reduced. Overall, we can say that the COVID-19 pandemic has had a negative impact on the market. The incidence of diabetic ulcers among the U.S. population has been estimated to be 2% annually, which is expected to support the growth of the market. In addition, traumatic events are on the rise in regions such as the Asia Pacific. Burns lead to the complete destruction of the skin rendering the wound bed dry. Therefore, an increasing number of such traumatic wounds is projected to boost the demand for wound therapeutics and subsequently the market.
The hospital segment dominated the market and accounted for the largest revenue share of 52.5% in 2021 owing to the fact that conventional devices are widely used in hospital settings. The home care setting is projected to be the fastest-growing segment with the highest CAGR during the forecast period. NPWT therapy for homecare settings is emerging with the introduction of single-use NPWT systems. These products eliminate the need for hospital stays and hence render the overall therapy cost-effective with its usage at home.
The pressure ulcer segment dominated the market and accounted for the largest revenue share of 31.3% in 2021 owing to longer treatment duration. Patients with pressure ulcers have to stay for longer durations when admitted to hospitals, thereby increasing hospital costs. Another factor contributing to such growth is its emerging application in treating pressure wounds such as bedsores. On the other hand, the diabetic foot ulcers segment is projected to witness the highest CAGR during the forecast period owing to its huge success rate in treating NPWT as well as the high prevalence of diabetes. Diabetic foot ulcers are the most common types of chronic wounds and NPWT expedites the healing process of such wounds. The other wound types, among others, include arterial ulcers and surgical wounds.
The conventional devices segment accounted for the largest revenue share of 88.0% in 2021 owing to their high price and increasing adoption. Such systems require hospital admission and are not suitable for homecare settings as they involve the use of heavy canisters. These devices can be rented as well as purchased, which is expected to increase the usage rate of NPWT in developing countries owing to its low purchasing power.
The single-use NPWT devices segment is expected to witness a lucrative CAGR during the forecast period. This is due to their wide applicability in home care settings, which has prompted major companies to focus on increasing their cost-effectiveness. This has proved to be an added advantage for single-use NPWT devices in developing countries.
North America held the largest revenue share of 38.9% in 2021 owing to rising healthcare expenditure and highly developed healthcare infrastructure in this region. This has led to greater adoption of NPWT devices in both hospitals as well as homecare settings. In the Asia Pacific, the market is anticipated to show a lucrative CAGR during the forecast period. This is mainly due to the increasing number of traumatic events such as burns which in turn is triggering the demand for therapy in this region.
The companies are focusing on mergers, acquisitions, new product development, and strategic collaboration strategies. For instance, in 2016, Acelity entered into a partnership agreement with Mediq with an aim to distribute its product offerings in advanced wound therapeutics and regenerative medicine in Finland, Denmark, Sweden, and Norway. In addition, ConvaTec launched Avelle NPWT System in the U.K. in 2016. These are advancing superior technologies, which are expected to foster the market growth in the long run. Some of the prominent players in the negative pressure wound therapy market include:
Acelity L.P. Inc.
Talley Group Limited
Nephew plc
Devon Medical Products
Mölnlycke Health Care
Medela
DeRoyal Industries, Inc.
ConvaTec, Inc.
Cardinal Health, Inc.
Paul Hartmann AG
Report Attribute |
Details |
Market size value in 2022 |
USD 2.3 billion |
Revenue forecast in 2030 |
USD 3.8 billion |
Growth Rate |
CAGR of 6.7% from 2022 to 2030 |
Base year for estimation |
2021 |
Historical data |
2018 - 2020 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2018 to 2030 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, wound type, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; India; China; Brazil; Mexico; South Africa |
Key Companies profiled |
Acelity L.P. Inc.; Talley Group Limited; Nephew plc; Devon Medical Products; Mölnlycke Health Care; Medela; DeRoyal Industries, Inc.; ConvaTec, Inc.; Cardinal Health, Inc.; Paul Hartmann AG |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global negative pressure wound therapy market report based on product, wound type, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Conventional NPWT
Single-use NPWT
Type Outlook (Revenue, USD Million, 2018 - 2030)
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcers
Burn Wounds
Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Homecare
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
China
India
Latin America
Brazil
Mexico
MEA
South Africa
b. Some key players operating in the negative pressure wound therapy market include 3 M Company, Talley Group Ltd, Smith & Nephew, Devon Medical Products, Molnlycke Health Care AB, Medela AG, DeRoyal Industries Inc., Covatec Inc. Cardinal Health, Paul Hartmann AG and Others
b. Key factors that are driving the negative pressure wound therapy market growth include increasing demand for advanced wound care, rising prevalence of chronic and acute wounds, rising number of surgeries, and technological advancements.
b. The global negative pressure wound therapy market size was estimated at USD 2.0 billion in 2021 and is expected to reach USD 2.3 billion in 2022.
b. The global negative pressure wound therapy market is expected to grow at a compound annual growth rate of 6.71% from 2022 to 2030 to reach USD 3.8 billion by 2030
b. North America dominated the hydrocolloid dressings market in 2021 during the forecast period and is expected to witness a growth rate of 6.02% over the forecast period. This can be attributed to the presence of key players, the presence of well-developed healthcare infrastructure, and rising demand for advanced treatment options, owing to the increasing prevalence of wounds, and growing efforts by the government to reduce the overall treatment duration.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.